Frank W. Marcoux
Algemeen Directeur bij Portage Glasgow Ltd.
Oorsprong van het eerstegraads netwerk van Frank W. Marcoux
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Opsidio LLC
Opsidio LLC Pharmaceuticals: MajorHealth Technology Opsidio LLC engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company is headquartered in Bryn Mawr, PA.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Portage Pharmaceutical Ltd.
Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Portage Pharma Ltd.
Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Frank W. Marcoux via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
TENAX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chief Executive Officer | |
Public Ventures LLC
Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Investment Banks/Brokers | Corporate Officer/Principal | |
PORTAGE BIOTECH INC. | Biotechnology | Director of Finance/CFO Founder Chief Executive Officer | |
Morphotek, Inc.
Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
PLETHORA SOLUTIONS HOLDINGS PLC | Pharmaceuticals: Major | Director/Board Member | |
Trojan Technologies USA LLC | Director/Board Member | ||
Secure Axcess LLC | Director/Board Member | ||
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
INTENSITY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Wayne State University (Michigan) | College/University | Doctorate Degree | |
University of Glasgow | College/University | Doctorate Degree | |
Philabundance
Philabundance Services to the Health IndustryHealth Services Philabundance provides food services to the community. The company was founded in 1984 by Pamela Rainey Lawler and is headquartered in Philadelphia, PA. | Services to the Health Industry | Director/Board Member | |
The University of Texas at Austin | College/University | Corporate Officer/Principal | |
Salem State University | College/University | Undergraduate Degree | |
University of Michigan | College/University | Undergraduate Degree | |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Baylor College of Medicine | College/University | Corporate Officer/Principal | |
NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Biotechnology | Corporate Officer/Principal | |
PRISM Technologies LLC
PRISM Technologies LLC Miscellaneous Commercial ServicesCommercial Services Part of Sabre Corp., PRISM Technologies LLC is a company that provides intellectual property licensing, and technology research and development services. The company is based in Omaha, NE. The company was founded by Gregory J. Duman. PRISM Technologies was acquired by Prism Technologies Group, Inc. on March 30, 2015 for $75.15 million. | Miscellaneous Commercial Services | Director/Board Member | |
Heptares Therapeutics Ltd.
Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer Europe International Ltd.
Pfizer Europe International Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Europe International Ltd. is an Irish company. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Knightsford Bank Corp. | Corporate Officer/Principal | ||
Zarwin, Baum, Devito, Kaplan, Schaer & Toddy P.C. | General Counsel | ||
Pfizer Japan, Inc.
Pfizer Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer Japan, Inc. is a research and Japanese development pharmaceutical company founded in 1953. The company is based in Tokyo, Japan. The company's focus is on breakthroughs that greatly change patients' lives, contributing to the improvement of patients' health and life expectancy. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Harvard T.H. Chan School of Public Health | College/University | Corporate Officer/Principal | |
University of Kent | College/University | Doctorate Degree | |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | Pharmaceuticals: Major | Director/Board Member | |
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Director/Board Member | |
The Pulmonary Vascular Research Institute
The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK. | Miscellaneous Commercial Services | Director/Board Member | |
University of Glasgow School of Medicine | College/University | Corporate Officer/Principal | |
iOX Therapeutics Ltd.
iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Director of Finance/CFO Chairman | |
Mediqventures Ltd.
Mediqventures Ltd. Finance/Rental/LeasingFinance Mediqventures Ltd. provides financing services for life science technologies. The private company is based in Douglas, UK. The British company was founded by Gregory H. Bailey. | Finance/Rental/Leasing | Founder Corporate Officer/Principal | |
SALVARX GROUP PLC | Biotechnology | Director of Finance/CFO Founder | |
Kleo Pharmaceuticals, Inc.
Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Kleo Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of biospecific compounds designed to emulate and enhance the activity of biologics. Its compounds are designed to direct the immune system to destroy cancerous or virally infected cells, and treatment of multiple myeloma and COVID-19. It offers Antibody Recruiting Molecules (ARMs),Synthetic Antibody Mimics (SyAMs), and Monoclonal Antibody Therapy Enhancers (MATEs) pipeline. The company was founded by David A. Spiegel and Roy Prieb in 2015 and is headquartered in New Haven, CT. | Miscellaneous Commercial Services | Director/Board Member | |
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Financial Conglomerates | Founder Founder | |
BYOMass, Inc.
BYOMass, Inc. Miscellaneous Commercial ServicesCommercial Services BYOMass, Inc. provides investment holding services. The company is headquartered in Sudbury, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
Causeway Therapeutics Ltd.
Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Causeway Therapeutics Ltd. operates as a biotechnology company. It develops drugs for the treatment for patients. The company was founded by Derek S. Gilchrist and Neal L. Millar and is headquartered in Glasgow, the United States. | Pharmaceuticals: Major | Chairman | |
Apterna Ltd. | Director/Board Member | ||
BIOHAVEN LTD. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Kitasato University | College/University | Corporate Officer/Principal |
Statistieken
Internationaal
Verenigde Staten | 28 |
Verenigd Koninkrijk | 15 |
Japan | 4 |
Ierland | 3 |
Australië | 2 |
Sectoraal
Health Technology | 24 |
Consumer Services | 11 |
Commercial Services | 7 |
Finance | 5 |
Health Services | 2 |
Operationeel
Director/Board Member | 47 |
Corporate Officer/Principal | 25 |
Founder | 17 |
Chairman | 14 |
Chief Executive Officer | 11 |
Sterkste connecties
Insiders | |
---|---|
Gregory Bailey | 36 |
Declan Doogan | 28 |
Kamlesh Shah | 10 |
Martin Phillips | 9 |
Alan E. Casnoff | 6 |
Kimberly Gentile | 6 |
Bruce H. Littman | 2 |
Holly Prentice | 1 |
Nicholas Lukacs | 1 |
John Oates | 1 |
- Beurs
- Insiders
- Frank W. Marcoux
- Bedrijfsconnecties